Showing 2861-2870 of 9967 results for "".
A Rational Criteria: When Not to Treat Warts
https://practicaldermatology.com/topics/infections-infectious-disease/a-rational-criteria-when-not-to-treat-warts/23813/How to decide which warts to let resolve on their own.A Protocol and Literature Review for Indocyanine Green in the Assessment of Periorbital and Facial Lymphatics
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-protocol-and-literature-review-for-indocyanine-green-in-the-assessment-of-periorbital-and-facial-lymphatics/24016/Getting to the Root of ACD
https://practicaldermatology.com/topics/atopic-dermatitis/getting-to-the-root-of-acd/20356/A practical approach to dermatitis in young and old.Investments 101: Calculating Capital Equipment Purchase and Procedure Costs
https://practicaldermatology.com/topics/general-topics/investments-101-calculating-capital-equipment-purchase-and-procedure-costs/21970/To make wise investments, clinicians must accurately estimate costs and know what they mean.A Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.Kybella Off-Label?
https://practicaldermatology.com/topics/practice-management/kybellaoff-label/21057/Experts weigh in on whether and how Kybella® may be used off-label.What's Next in Aesthetic Medicine?
https://practicaldermatology.com/topics/practice-management/whats-next-in-aesthetic-medicine/20523/Insights on the future of cosmetic care from DermTube.com.It’s A Hit! CSF Takes to Music City
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/its-a-hit-csf-takes-to-music-city/23199/If you weren’t at the meeting in Nashville, here’s what you missed.Preparing for Private Equity: Benefits and Drawbacks
https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/Over the past decade, the health care industry has emerged as a prime target for private equity (PE) investment.Don’t Pardon the Interruption
https://practicaldermatology.com/series/editors-message/dont-pardon-the-interruption/24021/